4//SEC Filing
Xenetic Biosciences, Inc. 4
Accession 0001662252-16-000299
$XBIOCIK 0001534525operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 1:58 PM ET
Size
12.2 KB
Accession
0001662252-16-000299
Insider Transaction Report
Form 4
DEPTULA-HICKS DARLENE M
Director
Transactions
- Award
Stock Option
2016-12-20+10,000→ 51,416 totalExercise: $3.50From: 2017-09-20Exp: 2026-12-20→ Common Stock (10,000 underlying) - Award
Stock Option
2016-12-20+10,000→ 61,416 totalExercise: $3.50From: 2017-12-20Exp: 2026-12-20→ Common Stock (10,000 underlying) - Award
Stock Option
2016-12-20+10,000→ 31,416 totalExercise: $3.50From: 2017-03-20Exp: 2026-12-20→ Common Stock (10,000 underlying) - Award
Stock Option
2016-12-20+10,000→ 41,416 totalExercise: $3.50From: 2017-06-20Exp: 2026-12-20→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months.
Documents
Issuer
Xenetic Biosciences, Inc.
CIK 0001534525
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001534525
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 1:58 PM ET
- Size
- 12.2 KB